Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
about
Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.CD30+ neoplasms of the skin.Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility.
P2860
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@en
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@nl
type
label
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@en
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@nl
prefLabel
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@en
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@nl
P2093
P1476
Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
@en
P2093
Lawrence M Weiss
Premi Thomas
Sean K Lau
P304
P356
10.1097/PAI.0B013E3181C81D31
P577
2010-05-01T00:00:00Z